Skip to content
10-Q

Quarterly Report

PROVECTUS BIOPHARMACEUTICALS, INC. PVCT

0001641172-25-023864

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 13, 2025 420.28M sh
Shares Diluted Q2 2025 · Jun 30, 2025 420.28M sh
Shares Diluted Q2 2025 · Jun 30, 2025 420.28M sh
Shares Diluted Q2 2025 · Jun 30, 2024 419.52M sh
Shares Diluted Q2 2025 · Jun 30, 2024 419.52M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$1.62M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$1.81M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $385.93K
Cash And Equivalents Q2 2025 · Jun 30, 2024 $29.58K
Stockholders Equity Q2 2025 · Jun 30, 2025 −$5.87M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$5.96M
Current Liabilities Q2 2025 · Jun 30, 2025 $6.49M
Current Liabilities Q2 2025 · Dec 31, 2024 $6.98M
Total Liabilities Q2 2025 · Jun 30, 2025 $6.6M
Total Liabilities Q2 2025 · Dec 31, 2024 $6.98M
Current Assets Q2 2025 · Jun 30, 2025 $568.32K
Current Assets Q2 2025 · Dec 31, 2024 $976.77K
Total Assets Q2 2025 · Jun 30, 2025 $722.38K
Total Assets Q2 2025 · Dec 31, 2024 $1.01M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2024 $0.00
Eps Diluted Q2 2025 · Jun 30, 2024 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2024 $0.00
Eps Basic Q2 2025 · Jun 30, 2024 $0.00
Sga Expense Q2 2025 · Jun 30, 2025 $990.86K
Sga Expense Q2 2025 · Jun 30, 2025 $1.98M
Sga Expense Q2 2025 · Jun 30, 2024 $576.92K
Sga Expense Q2 2025 · Jun 30, 2024 $706.72K
Rd Expense Q2 2025 · Jun 30, 2025 $867.35K
Rd Expense Q2 2025 · Jun 30, 2025 $1.26M
Rd Expense Q2 2025 · Jun 30, 2024 $472.93K
Rd Expense Q2 2025 · Jun 30, 2024 $1.03M
Net Income Q2 2025 · Jun 30, 2025 −$1.81M
Net Income Q2 2025 · Jun 30, 2025 −$2.95M
Net Income Q2 2025 · Jun 30, 2024 −$846.85K
Net Income Q2 2025 · Jun 30, 2024 −$1.35M
Operating Income Q2 2025 · Jun 30, 2025 −$1.8M
Operating Income Q2 2025 · Jun 30, 2025 −$2.9M
Operating Income Q2 2025 · Jun 30, 2024 −$794.85K
Operating Income Q2 2025 · Jun 30, 2024 −$1.24M
Revenue Q2 2025 · Jun 30, 2025 $57.48K
Revenue Q2 2025 · Jun 30, 2025 $336.11K
Revenue Q2 2025 · Jun 30, 2024 $254.99K
Revenue Q2 2025 · Jun 30, 2024 $493.06K